AstraZeneca PLC
- BID
146.85
- ASK
147.1
- 138 Units138 Units
- 07/23, 09:39:45 AM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
26.60%
Market Cap
229.84 Bil.
P/E Ratio
27.55
Dividend Yield
1.71 %
Earnings per Share
5.85 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 146.75 G | 0 Units |
| PRICE DETERMINATION TIME | 07/23/2026 / 09:33:50 AM | |
| DAILY VOLUME (UNITS) | 3 | |
| DAILY HIGH / LOW | 148.6 | 146.25 |
| PREV. DAY'S PRICE | 148.2 | (07/22) |
| CHANGE DAY BEFORE | -1.45 | -0.98 % |
| 52 WEEK HIGH / LOW | 180.65 (02/18) | 117.6 (07/22) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 3.56 | 4.20 | 5.85 | 8.98 | 10.08 |
DIVIDENDS PER SHARE | 2.62 | 2.90 | 2.76 | 2.89 | 3.03 |
DIVIDEND YIELD IN % | 2.15 % | 2.35 % | 1.71 % | - | - |
DIVIDEND GROWTH IN % | -6.89 % | 10.75 % | -4.86 % | - | - |
PRICE - EARNINGS RATIO | 34.27 | 29.47 | 27.55 | 16.31 | 14.52 |
PRICE - BOOK RATIO | 5.35 | 4.98 | 5.91 | - | - |
PRICE - SALES RATIO | 4.49 | 3.87 | 4.83 | - | - |
PRICE - CASH FLOW RATIO | 19.36 | 17.13 | 19.10 | - | - |
Master Data
| WKN | 886455 |
| ISIN | GB0009895292 |
| SYMBOL | ZEG |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Astra Zeneca |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | British Pound Sterling |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 1.55 Bil. |
| MARKET CAPITALISATION | 229.84 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 2.92 % | -1.79 % | -11.31 % | -4.42 % | 26.60 % | 20.09 % | 50.84 % | -5.24 % |
| HIGH | 148.65 | 171.10 | 171.10 | 180.65 | 180.65 | 180.65 | 180.65 | 180.65 |
| LOW | 143.85 | 143.85 | 143.85 | 143.85 | 117.60 | 110.00 | 93.76 | 143.85 |
Dividende
pro Aktie
Company profile
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
Structured products for AstraZeneca PLC
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.